Cite
HARVARD Citation
Beigel, J. et al. (2018). Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study. Lancet infectious diseases. 18 (4), pp. 410-418. [Online].